Valuation: J. B. Chemicals & Pharmaceuticals Limited

Capitalization 304B 3.35B 2.83B 2.58B 2.46B 4.57B 4.75B 29.99B 11.9B 147B 12.58B 12.32B 513B P/E ratio 2026 *
37.5x
P/E ratio 2027 * 31.7x
Enterprise value 297B 3.28B 2.76B 2.52B 2.41B 4.47B 4.64B 29.31B 11.64B 143B 12.3B 12.05B 501B EV / Sales 2026 *
6.92x
EV / Sales 2027 * 6.07x
Free-Float
45.74%
Yield 2026 *
0.84%
Yield 2027 * 0.91%
1 day-0.63%
1 week+2.28%
Current month+1.20%
1 month+1.35%
3 months+4.04%
6 months+10.33%
Current year+3.97%
1 week 1,849.25
Extreme 1849.25
1,927
1 month 1,777.05
Extreme 1777.05
1,935
Current year 1,777.05
Extreme 1777.05
1,939.3
1 year 1,303
Extreme 1303
1,939.3
3 years 914.65
Extreme 914.65
2,029
5 years 538.65
Extreme 538.65
2,029
10 years 115.5
Extreme 115.5
2,029
Manager TitleAgeSince
Chief Executive Officer 53 04/10/2020
Chief Tech/Sci/R&D Officer 49 29/03/2021
Chief Administrative Officer 59 14/09/2016
Director TitleAgeSince
Director/Board Member 71 30/08/2020
Director/Board Member 69 13/05/2025
Director/Board Member 62 09/07/2025
Change 5d. change 1-year change 3-years change Capi.($)
-0.63%+2.28%+12.29%+94.30% 3.35B
+0.33%-1.72%+23.18%+199.23% 929B
-0.45%+1.44%+55.91%+50.24% 587B
+1.76%+3.61%+20.03%+51.71% 409B
+0.08%+1.01%+20.89%+28.94% 374B
+1.42%+7.19%+26.36%+32.36% 320B
+1.08%+4.32%+27.98%+55.61% 311B
+1.82%-0.43%+46.26%+11.65% 301B
+1.32%+5.11%-45.12%-37.51% 219B
+1.52%-3.94%+26.80%+53.17% 199B
Average +0.82%+2.03%+21.46%+53.97% 365.21B
Weighted average by Cap. +0.74%+1.58%+26.53%+76.77%

Financials

2026 *2027 *
Net sales 42.94B 474M 399M 364M 348M 646M 671M 4.24B 1.68B 20.74B 1.78B 1.74B 72.47B 48.37B 534M 450M 410M 392M 727M 756M 4.77B 1.9B 23.36B 2B 1.96B 81.64B
Net income 7.87B 86.92M 73.24M 66.8M 63.78M 118M 123M 777M 308M 3.8B 326M 319M 13.29B 9.3B 103M 86.53M 78.93M 75.35M 140M 145M 918M 364M 4.49B 385M 377M 15.7B
Net Debt -6.81B -75.17M -63.34M -57.77M -55.15M -102M -106M -672M -267M -3.29B -282M -276M -11.49B -10.03B -111M -93.35M -85.14M -81.29M -151M -157M -990M -393M -4.85B -415M -407M -16.94B
Logo J. B. Chemicals & Pharmaceuticals Limited
J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing of medicated and herbal lozenges. All its lozenges (herbal, medicated and soft-centered) can be made in sugar and sugar-free options. It has implemented osmotic-controlled release oral drug delivery system (OROS) technology. It maintains a direct presence in Russia and South Africa, along with distributor relationships in the United States and various markets throughout Asia, Africa, and Latin America.
Employees
5,304
Date Price Change Volume
13/02/26 1,892.70 -0.63% 3,964
12/02/26 1,904.75 +0.41% 7,580
11/02/26 1,896.90 -1.39% 3,977
10/02/26 1,923.55 +2.10% 4,132
09/02/26 1,884.00 +1.81% 3,159
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
1,892.70INR
Average target price
2,118.09INR
Spread / Average Target
+11.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. JBCHEPHARM Stock